Legal Representation
Attorney
Eric Lamb
USPTO Deadlines
Next Deadline
17 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
August 02, 2025
Application History
29 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 2, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jun 2, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 5, 2024 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Dec 5, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 5, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Dec 5, 2024 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Dec 4, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 24, 2024 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Sep 24, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 24, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 24, 2024 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Apr 30, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 29, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 29, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 29, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 31, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 5, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 5, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 16, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 1, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 31, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 31, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 31, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 26, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 26, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 26, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 16, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 19, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 3, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Diagnostic preparations for medical purposes; Drug delivery agents in the form of powders, tablets, capsules, solutions, cells and nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Tumor suppressing agents; Pharmaceutical products for the prevention and treatment of cancer; Medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biological preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biochemical medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCES"